Zobrazeno 1 - 10
of 39
pro vyhledávání: '"M H, Goldrosen"'
Autor:
J. Sweeney, R. A. Dennin, Zale P. Bernstein, J. Park, D Vesper, J. Zeffren, Louis Vaickus, H. Takita, Kenneth A. Foon, R. Rahman, H. Watanabe, N. Friedman, Susan G. Arbuck, M H Goldrosen
Publikováno v:
Journal of Immunotherapy. 10:383-387
A phase II study was conducted to examine the efficacy of interleukin-2 (IL-2) with lymphokine-activated killer (LAK) cells as therapy for advanced non-small-cell lung carcinoma (NSCLC). IL-2 was administered at a fixed dose of 6 x 10(6) U/M2 per day
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1c1b320fd25ffb83f1b94c8b7355116
https://doi.org/10.1097/00002371-199110000-00012
https://doi.org/10.1097/00002371-199110000-00012
Autor:
Z. P. Bernstein, L. Vaickus, N. Friedman, M. H. Goldrosen, H. Watanabe, R. Rahman, S. G. Arbuck, J. Sweeney, D. Vesper, E. D. Henderson, J. Zeffren, R. A. Dennin, D. Levitt, K. A. Foon
Publikováno v:
Journal of Immunotherapy. 10:141-146
We conducted a phase II study utilizing interleukin-2 (IL-2) with lymphokine-activated killer (LAK) cells as therapy for non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD). IL-2 was given at a fixed dose of 3 x 10(6) U/m2/day administered as a 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3269a3df0a39215363780d3e78d19e9a
https://doi.org/10.1097/00002371-199104000-00008
https://doi.org/10.1097/00002371-199104000-00008
Publikováno v:
Anticancer research. 12(6B)
The effects of an anti-CD3 mAb on induction of non-MHC restricted cytolysis was investigated. Peripheral blood mononuclear cells (PBMC) from normal donors (29) and cancer patients (18) were cultured in 100 U/ml of interleukin-2 (rIL-2) with and witho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::410f5c8bd859666ed1f7255c77f8cc74
https://pubmed.ncbi.nlm.nih.gov/1295440
https://pubmed.ncbi.nlm.nih.gov/1295440
Autor:
M H, Goldrosen, W C, Biddle, J, Pancook, S, Bakshi, J L, Vanderheyden, A R, Fritzberg, A C, Morgan, K A, Foon
Publikováno v:
Cancer research. 50(24)
Biodistribution, pharmacokinetic, and radioimaging studies were performed with 186Re-labeled NR-LU-10 whole antibody in athymic nude mice bearing the LS174T tumor growing either s.c. or in an experimental hepatic metastasis model. NR-LU-10 is an IgG2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::555cf633b33406b9ac20e45fcf01cc72
https://pubmed.ncbi.nlm.nih.gov/2253238
https://pubmed.ncbi.nlm.nih.gov/2253238
Publikováno v:
Cancer research. 50(6)
Liver-derived (LD) murine colon adenocarcinoma MCA-38 cells injected into the ileocolic vein (ICV) of C57BL/6 mice developed distinct hepatic foci within 14-21 days and survived for an average of 19-35 days. In contrast, C57BL/6-nu/nu mice given inje
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::676ed092b2ceeb10fb49ccb40af6be24
https://pubmed.ncbi.nlm.nih.gov/2306736
https://pubmed.ncbi.nlm.nih.gov/2306736
Publikováno v:
Diseases of the Colon & Rectum. 20:561-565
The in-vitro lymphocytotoxic responses of 27 preoperative colonic-carcinoma patients and 61 healthy volunteers were correlated with age by linear regression analysis. Cytotoxicity obtained with leukocytes from the colonic-cancer patients on the colon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed60111b9ea17b3990f04f370529ffc7
https://doi.org/10.1007/bf02586618
https://doi.org/10.1007/bf02586618
Murine Colon Adenocarcinoma: Syngeneic Orthotopic Transplantation and Subsequent Hepatic Metastases2
Publikováno v:
JNCI: Journal of the National Cancer Institute. 59:1537-1544
Syngeneic murine colon adenocarcinoma (MCA-38) cells were transplanted in the submucosa of distal colon, proximal colon, cecum, ileum, jejunum, and duodenum of male C57BL/6 mice, with local lymphoid follicles used as points of entry. The tumor grew b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::db450694f7e28dcbde4b133f0099a8e1
https://doi.org/10.1093/jnci/59.5.1537
https://doi.org/10.1093/jnci/59.5.1537
Publikováno v:
JNCI: Journal of the National Cancer Institute. 56:871-873
Two murine colon adenocarcinoma cell lines were established from primary cultures. The MCA-38 cell line was begun by treatment of the primary culture with trypsin to remove the fibroblastoid elements. The MCA-36 epithelial cells were sensitive to try
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::02cf9bcc9d5344ca87919667780d1074
https://doi.org/10.1093/jnci/56.4.871
https://doi.org/10.1093/jnci/56.4.871
Autor:
M. H. Goldrosen, Peter B. Dent
Publikováno v:
Immunological communications. 6(2)
In order to determine if progressively growing tumors specifically bind antitumor antibody, which might play a role in blocking tumor specific cell-mediated immunity, low pH elutions were performed on autochthonous and transplantable SV40 tumors grow
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4067547b2b6205047759bc094f37215e
https://pubmed.ncbi.nlm.nih.gov/193780
https://pubmed.ncbi.nlm.nih.gov/193780
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 121(5)
To study the cellular basis for specific antigen-induced leukocyte adherence inhibition, enriched populations of B cells, T cells, and monocytes were prepared by a two-stage adherence separation procedure from spleen cells of normal C57BL/6J mice and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8d3631b58afe48122278995fa0493afc
https://pubmed.ncbi.nlm.nih.gov/81856
https://pubmed.ncbi.nlm.nih.gov/81856